ZR202a-CoV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZR202a-CoV, covering 2023-04-20 to 2023-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults. [Phase 1, Phase 2]